Target of New Cancer Treatment Valid for Breast as Well as Blood Cancers: Study (IMAGE)
Caption
University of Alberta oncology researcher John Mackey (left) and cell biologist Luc Berthiaume are collaborators on new research showing that PCLX-001, an anti-cancer drug set to begin clinical trials this year, may work against breast cancer as well as lymphoma.
Credit
University of Alberta
Usage Restrictions
None
License
Licensed content